Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Notley

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Journal of Thrombosis and Haemostasis : JTH|April 26, 2006
Genetic linkage and association analysis in type 1 von Willebrand disease: results from the Canadian type 1 VWD studyP D James, A D Paterson, C Notley, et al.
Journal of Thrombosis and Haemostasis : JTH|June 30, 2011
Expanded phenotype-genotype correlations in a pediatric population with type 1 von Willebrand diseaseJ D Robertson, P R Yenson, M L Rand, et al.
Blood|January 3, 2001
Systemic delivery of an adenoviral vector encoding canine factor VIII results in short-term phenotypic correction, inhibitor development, and biphasic liver toxicity in hemophilia A dogsA M Gallo-Penn, P S Shirley, J L Andrews, et al.
Human Gene Therapy|August 14, 1999
In vivo evaluation of an adenoviral vector encoding canine factor VIII: high-level, sustained expression in hemophiliac miceA M Gallo-Penn, P S Shirley, J L Andrews, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Journal of Thrombosis and Haemostasis : JTH|April 26, 2006
Genetic linkage and association analysis in type 1 von Willebrand disease: results from the Canadian type 1 VWD studyP D James, A D Paterson, C Notley, et al.
Journal of Thrombosis and Haemostasis : JTH|June 30, 2011
Expanded phenotype-genotype correlations in a pediatric population with type 1 von Willebrand diseaseJ D Robertson, P R Yenson, M L Rand, et al.
Blood|January 3, 2001
Systemic delivery of an adenoviral vector encoding canine factor VIII results in short-term phenotypic correction, inhibitor development, and biphasic liver toxicity in hemophilia A dogsA M Gallo-Penn, P S Shirley, J L Andrews, et al.
Human Gene Therapy|August 14, 1999
In vivo evaluation of an adenoviral vector encoding canine factor VIII: high-level, sustained expression in hemophiliac miceA M Gallo-Penn, P S Shirley, J L Andrews, et al.
Pageof 2